SUMMARY
Thrombelastography (TEG) has been accepted as a useful monitor of perioperative coagulation since its successful clinical use in liver transplantation 1 . The TEG displays the formation (thrombosis) and breakdown (fibrinolysis) of a whole blood clot and therefore provides a visual pattern of functional clotting status. TEG parameters include reaction time (r value, normal 19 to 28 mm) representing the time for initial fibrin formation, coagulation time (k value, normal 8 to 13 mm) and the clot formation rate (α angle, normal 29° to 43°) representing measures of the speed of clot strengthening, and maximum amplitude (MA, normal 48 to 60 mm) representing maximum clot strength. The fibrinolytic index for traditional non-computerized TEG is whole blood clot lysis index (WBCLI, normal >85%) which is amplitude 60 minutes after the MA (MA 60) as a percentage of MA and represents the amount of clot retraction or lysis(LY) 2 . Computerized TEG reports LY 30 and LY 60 (%) as fibrinolytic indices. These indices measure the reduction in the area under the TEG tracing from the time MA is measured until 30 (LY 30, normal <7.5%) or 60 (LY 60, normal <15%) minutes after the MA 3 . TEG is a uniquely sensitive test for fibrinolysis or disseminated intravascular coagulation (DIC) [4] [5] [6] . We report here a case where TEG was useful in the early detection of fibrinolysis and monitoring of the effect of antifibrinolytic therapy following hip surgery.
CASE HISTORY
A 79-year-old man was scheduled for left total hip replacement. He had a history of non-insulindependent diabetes, hypertension and chronic renal insufficiency (serum creatinine 0.165 mmol.l -1 ). His usual medications included nifedipine, salbutamol, resonium and Panadeine Forte (paracetamol and codeine). The patient had a transfusion of two units of packed red blood cells for anaemia and had been receiving subcutaneous heparin therapy (5000 U, twice a day) for five days. This was administered as prophylaxis for venous thromboembolism because the patient was relatively immobile in hospital receiving treatment for his medical condition.
The preoperative coagulation profile (prothrombin time (PT), international normalized ratio for prothrombin time (INR), activated partial thromboplastin time (aPTT), fibrinogen and D-dimer), liver function tests, blood potassium and glucose were normal. The haemoglobin concentration was 11 g.dl -1 and the platelet count was 125x10 9 .l -1 . The cause of this mild thrombocytopenia was not elucidated.
No premedication was given. Spinal anaesthesia was performed with 4.5 ml of 0.5% plain bupivacaine and sedation administered during the operation included intermittent bolus doses of midazolam (0.5 to 1 mg) and propofol (20 to 30 mg). Central venous pressure was monitored and the patient received continuous intravenous infusion of dopamine (3 µg.kg -1 .min -1 ) throughout the operation and until the first postoperative day. Intravenous cefazolin 1 g was given intraoperatively.
The duration of the operation was 110 minutes and haemodynamics were stable. Blood loss was one litre and two units of packed red blood cells were transfused intraoperatively. At the end of surgery, considerable blood oozing occurred at the site of the wound closure. In the postoperative recovery room, the amount of serosanguinous drainage from the wound was 600 ml within the first postoperative hour.
As part of a coagulation research project, the patient was monitored perioperatively with TEG (Thrombelastography D, Haemoscope, Skokie, IL). The pre-anaesthesia baseline TEG was normal ( Figure 1 ). The intraoperative TEG (from a blood sample taken in the middle of surgery) showed a hypocoagulable state indicated by prolonged r and k values, and a reduced angle. The MA was normal ( Figure 2 ). The postoperative TEG (30 minutes after surgery) showed a fibrinolytic pattern ( Figure  3 ). Subsequent coagulation tests (Table 1) showed a normal clotting profile except for a markedly increased D-dimer (8 to 16 mg.l -1 ). Crossmatched blood that had been transfused intraoperatively was rechecked and no incompatibility could be identified.
The patient was then treated with a bolus injection of intravenous epsilon aminocaproic acid (ε-ACA) 5 g. Blood drainage diminished markedly. Three hours after the initiation of this antifibrinolytic therapy, the TEG showed a degree of hypocoagulability but fibrinolysis was no longer apparent ( Figure 4 ). The patient received one more unit of packed red blood cells. Five hours after the administration of ε-ACA, the TEG was normal ( Figure 5 ) and the D-dimer level had decreased to 1 to 2 mg.l -1 . TEG tracings were normal at days 1, 3 and 5 postoperatively. On day 7 postoperatively, unilateral venography (also part of the coagulation research study) revealed no evidence of deep venous thrombosis on the operated limb.
DISCUSSION TEG has been routinely used to monitor coagulation and to guide blood product therapy in liver transplantation in this institution and has been confirmed as a useful method for the monitoring of bedside coagulation. A TEG indicating fibrinolysis is often seen during liver transplantation. Simultaneous laboratory analysis usually corroborates fibrinolysis with reduced fibrinogen level, shortened euglobulin clot lysis time and elevated D-dimer 2 . In contrast, it is unusual to detect fibrinolysis on TEG during surgical procedures other than liver transplantation and occasionally in cardiac surgery. In all our clinical studies with perioperative TEG monitoring, this case was the only one with a TEG tracing showing fibrinolysis out of more than 1000 blood samples in 183 patients undergoing vascular, orthopaedic, lung, abdominal and urology surgery.
The TEG changes reflecting fibrinolysis commonly show slight prolongation of r and k times and a reduction in MA. The diagnostic feature, however, is the increase in LY 30 and LY 60 on computerized TEG or reduced WBCLI on traditional TEG. Primary fibrinolysis is indicated by near normal values of r and k in contrast to secondary fibrinolysis in which r and k values are markedly prolonged 7, 8 . TEG can be used to determine the response to antifibrinolytic therapy more rapidly and more accurately than other methods now being used 9 . In this case, TEG showed a typical primary fibrinolytic tracing. normal TEG parameters for clot lysis after ε-ACA treatment together with a marked decrease in blood drainage provided further evidence for the diagnosis of primary fibrinolysis. Disseminated intravascular coagulation was initially considered but this diagnosis was not supported by conventional coagulation tests (Table 1) . In vitro TEG studies with blood samples taken from the same patient and propofol, cefazolin and bone cement that were used intraoperatively did not show fibrinolysis. The intraoperative TEG showing hypocoagulability is uncommon except during liver transplantation and cardiac surgery using cardiopulmonary bypass. Previous reports 10, 11 and our perioperative observations show enhanced coagulation (shortened r and k times) is more common during and after operation. Prolonged r and k values and a smaller α angle without changes in MA indicate coagulation factor deficiencies that may be related to blood loss and chronic renal insufficiency. D-dimer (cross-linked fibrin degradation fragment) is one of the commonly used laboratory tests for the identification of fibrinolysis 12 . Its marked elevation shortly after the operation in this case is consistent with the TEG diagnosis of fibrinolysis. There was no change in plasma fibrinogen concentration in the recovery room. Some studies have demonstrated that fibrinolysis can be detected by sensitive clot assay techniques without significant plasminogen or fibrinogen reductions 8, 12 . It is concluded that the TEG is a useful monitor of fibrinolysis and can provide clinically important information. In conjunction with clinical observation and conventional coagulation tests, TEG can also be used to monitor the effect of antifibrinolytic therapy. In this case, the TEG facilitated early detection of fibrinolysis and enabled institution of appropriate therapy and monitoring of the patient's response. In the absence of the TEG diagnosis of fibrinolysis and subsequent antifibrinolytic treatment, it is likely that the patient would have been given extra blood products and may have continued to bleed enough to warrant surgical re-exploration. 
